Comparison between Anawil Wire & Engineering IPO and Injecto Polymers IPO.
Anawil Wire & Engineering IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Injecto Polymers IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Anawil Wire & Engineering IPO is up to ₹0.00 Cr whereas the issue size of the Injecto Polymers IPO is up to ₹0.00 Cr. The final issue price of Anawil Wire & Engineering IPO is and of Injecto Polymers IPO is .
| Anawil Wire & Engineering IPO | Injecto Polymers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 52,84,000 shares | 56,13,500 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 13,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 65,84,000 shares | 56,13,500 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Anawil Wire & Engineering IPO opens on , while Injecto Polymers IPO opens on . The closing date of Anawil Wire & Engineering IPO and Injecto Polymers IPO is , and , respectively.
Anawil Wire & Engineering IPO P/E ratio is , as compared to Injecto Polymers IPO P/E ratio of .
| Anawil Wire & Engineering IPO | Injecto Polymers IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anawil Wire & Engieering Ltd.'s revenue increased by 47% and profit after tax (PAT) rose by 180% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Injecto Polymers Ltd.'s revenue increased by 138% and profit after tax (PAT) rose by 82% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.35 | 88.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.28 | 23.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.84 | 13.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.37 | 2.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.71 | 17.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anawil Wire & Engineering IPO Retail Individual Investors (RII) are offered 0 shares while in Injecto Polymers IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Anawil Wire & Engineering IPO and 0 shares in Injecto Polymers IPO.
| Anawil Wire & Engineering IPO | Injecto Polymers IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Anawil Wire & Engineering IPO subscribed in total, whereas Injecto Polymers IPO subscribed .